An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Clinical trial NCT02103426 · COMPLETED

Trial details

NCT number: NCT02103426
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dialysis Healthy Subjects Cytomegalovirus Infection

Start date: 2013-12-30
Primary completion: 2016-05-10
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.